conivaptan has been researched along with Inappropriate ADH Syndrome in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 17 (54.84) | 29.6817 |
2010's | 14 (45.16) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernard, P; Gardner, B; Kuhn, R; Peters, S | 1 |
Aghi, MK; Blevins, L; Jahangiri, A; Kunwar, S; Miller, LM; Tom, MW; Tran, MT; Wagner, J | 1 |
Blevins, LS; Breshears, JD; Jiang, B; Kunwar, S; Rowland, NC | 1 |
Kilonzo, K; Lee, JJ; Nistico, A; Yeates, K | 1 |
Laczi, F | 1 |
Asbury, WH; Gilmore, JL; Samuels, OB; Wright, WL | 1 |
Dhar, R; Diringer, M; Murphy, T | 1 |
Glezerman, IG | 1 |
Arthur, JM; Delay, TA; Dopson, SJ; Sanders, DS; Velez, JC | 1 |
Gross, P | 1 |
Carluccio, AL; Merlin, MA; Zenenberg, RD | 1 |
Villabona, C | 1 |
Er, F; Fuhr, U; Gassanov, N; Nia, AM; Semmo, M; Semmo, N | 1 |
Decaux, G; Gross, PA; Wagner, A | 1 |
Bianzina, S; Dal Canton, A; Esposito, P; Malul, Y; Piotti, G | 1 |
Blevins, LS; DeGiacomo, AF; Deragopian, L; Potts, MB | 1 |
Caimi, G; Urso, C | 1 |
Peri, A | 1 |
Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G | 1 |
Streefkerk, JO; van Zwieten, PA | 1 |
Gross, P; Herbrig, K; Palm, C; Pistrosch, F | 1 |
Arai, Y; Fujimori, A; Matsukawa, U; Miyata, K; Sasamata, M; Sudoh, K; Wada, K | 1 |
Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P | 1 |
Berl, T; Ellison, DH | 1 |
Lien, YH; Shapiro, JI | 1 |
Głuszek, J; Olszewski, W | 1 |
Siegel, AJ | 1 |
Cain, JP; Rianthavorn, P; Turman, MA | 1 |
Decaux, G | 1 |
Bichet, DG; Davids, MR; Edoute, Y; Halperin, ML; Mallie, JP | 1 |
18 review(s) available for conivaptan and Inappropriate ADH Syndrome
Article | Year |
---|---|
Management of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Disease Management; Female; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Male; Morpholines; Prognosis; Pyrroles; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Spiro Compounds; Tolvaptan; Treatment Outcome | 2014 |
[Etiology, diagnostics and therapy of hyponatremias].
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins | 2008 |
Tolvaptan (Samsca) for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiomyopathy, Dilated; Clinical Trials as Topic; Drug Approval; Drug Interactions; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Osmolar Concentration; Tolvaptan; United States; United States Food and Drug Administration | 2009 |
Hyponatremia: evaluation and management.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Urea Nitrogen; Cardiac Output, Low; Causality; Diagnosis, Differential; Glomerular Filtration Rate; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules; Saline Solution, Hypertonic; Sodium; Tolvaptan; Uric Acid; Water-Electrolyte Balance | 2010 |
[Vasopressin receptor antagonists: the vaptans].
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins | 2010 |
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Biological; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan; Water-Electrolyte Balance | 2011 |
Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Costs; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan | 2011 |
The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options.
Topics: Animals; Benzazepines; Disease Management; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neurophysins; Protein Precursors; Vasopressins; Water-Electrolyte Balance | 2011 |
[Hyponatremic syndrome].
Topics: Aging; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Brain; Brain Edema; Exercise; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infections; Inflammation; Kidney; Natriuresis; Neoplasms; Osmotic Pressure; Renal Replacement Therapy; Sodium; Tolvaptan; Water Intoxication | 2012 |
Clinical review: the use of vaptans in clinical endocrinology.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Discovery; Endocrinology; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Models, Biological; Tolvaptan | 2013 |
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins | 2003 |
Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Drug Design; Heart Failure; Hormone Antagonists; Humans; Hypertension; Inappropriate ADH Syndrome; Indoles; Presynaptic Terminals; Pyrrolidines; Receptors, Vasopressin; Renal Artery; Sympathetic Nervous System; Synaptic Transmission; Tolvaptan; Vasoconstriction; Vasoconstrictor Agents | 2006 |
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Vasopressins | 2006 |
Therapeutic potential of vasopressin receptor antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan | 2007 |
Clinical practice. The syndrome of inappropriate antidiuresis.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Carcinoma, Small Cell; Dysgeusia; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Lung Neoplasms; Middle Aged; Osmolar Concentration; Saline Solution, Hypertonic; Urine | 2007 |
Hyponatremia: clinical diagnosis and management.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney; Kidney Concentrating Ability; Kidney Tubules, Collecting; Male; Osmolar Concentration; Vasopressins | 2007 |
[Vasopressin antagonists in treatment of hyponatremia].
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Sodium Chloride; Tolvaptan; Water-Electrolyte Balance | 2007 |
Hyponatremia in psychiatric patients: update on evaluation and management.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drinking Behavior; Humans; Hyponatremia; Inappropriate ADH Syndrome; Mental Disorders; Psychotropic Drugs; Risk Factors; Water-Electrolyte Balance | 2008 |
13 other study(ies) available for conivaptan and Inappropriate ADH Syndrome
Article | Year |
---|---|
Use of conivaptan for refractory syndrome of inappropriate secretion of antidiuretic hormone in a pediatric patient.
Topics: Accidents, Traffic; Benzazepines; Humans; Inappropriate ADH Syndrome; Infant; Male | 2013 |
Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Child, Preschool; Female; Humans; Hyponatremia; Hypopituitarism; Inappropriate ADH Syndrome; Male; Middle Aged; Neurosurgical Procedures; Pituitary Gland; Postoperative Complications; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome; Young Adult | 2013 |
Use of conivaptan for management of hyponatremia following surgery for Cushing's disease.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cushing Syndrome; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Male; Middle Aged; Pituitary Neoplasms; Retrospective Studies; Sodium; Water Deprivation | 2013 |
Conivaptan for hyponatremia in the neurocritical care unit.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Critical Care; Drug Monitoring; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Receptors, Vasopressin; Retrospective Studies; Sodium; Young Adult | 2009 |
Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Critical Care; Dose-Response Relationship, Drug; Humans; Hyponatremia; Inappropriate ADH Syndrome; Pulse Therapy, Drug; Retrospective Studies; Sodium; Specific Gravity; Urine | 2009 |
Successful treatment of ifosfamide-induced hyponatremia with AVP receptor antagonist without interruption of hydration for prevention of hemorrhagic cystitis.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Benzazepines; Cystitis; Fluid Therapy; Humans; Ifosfamide; Inappropriate ADH Syndrome; Lymphoma, AIDS-Related; Male | 2009 |
Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Urea Nitrogen; Female; Glomerular Filtration Rate; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Male; Middle Aged; Sodium | 2010 |
The vaptans: just landed. But how was the trip?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome | 2010 |
Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion.
Topics: Adult; Aged; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Injections, Intravenous; Male; Middle Aged; Retrospective Studies | 2011 |
A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Furosemide; Hyponatremia; Inappropriate ADH Syndrome; Injections, Intravenous; Male; Osmolar Concentration; Potassium; Rats; Rats, Wistar; Sodium; Water; Water-Electrolyte Balance | 2007 |
Use of conivaptan to allow aggressive hydration to prevent tumor lysis syndrome in a pediatric patient with large-cell lymphoma and SIADH.
Topics: Adolescent; Benzazepines; Fluid Therapy; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lymphoma, Large B-Cell, Diffuse; Male; Severity of Illness Index; Tumor Lysis Syndrome | 2008 |
Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Female; Furosemide; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Urea | 2001 |
Body compartment volumes and composition after giving a vasopressin antagonist: changes are revealed by a tonicity balance.
Topics: Benzazepines; Body Fluid Compartments; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged; Potassium; Receptors, Vasopressin; Sodium | 2002 |